FDA executives committed to 'scientific evidence' amid pandemic
Eight senior executives with the Food and Drug Administration joined forces Thursday to reiterate the agency's commitment to maintaining independence and following "scientific evidence" amid the ongoing pandemic.
"Maintaining the American public’s trust in the FDA is vital. If the agency’s credibility is lost because of real or perceived interference, people will not rely on the agency’s safety warnings," the executives wrote in a USA Today op-ed published Thursday. "Erosion of public trust will leave consumers and patients doubting our recommendations, less likely to enroll in clinical studies or to use FDA-regulated products when they should to maintain or improve their health."
They added: "This is problematic under normal circumstances but especially if we are to ultimately overcome COVID-19. Protecting the FDA’s independence is essential if we are to do the best possible job of protecting public health and saving lives."
The executives, who oversee various FDA centers around the county, said the agency is committed to providing science-based regulations and safety protocols despite operating "in a political environment" during the pandemic.
"We absolutely understand that the FDA, like other federal executive agencies, operates in a political environment. That is a reality that we must navigate adeptly while maintaining our independence to ensure the best possible outcomes for public health," the executives wrote. "When it comes to decisions to authorize or approve the products we regulate, or to take appropriate action when we uncover safety issues, we and our career staff do the best by public health when we are the decision-makers, arriving at those decisions based on our unbiased evaluation of the scientific evidence."